Takara Bio
Präsenz
Takara ist einer der ...
Takara ist ein Unternehmen, das unter dem Börsenticker 2531 (JP) gelistet ist.
Takara hat eine direkte Präsenz in 2 Ländern.
Sie befinden sich in:
- Weine & Spirituosen33%
- Biotechnologie33%
- Andere33%
Führungskräfte
Siehe das Organigramm mit seine 13 wichtigsten Führungskräfte
Die meist gesuchten Biographien bei Takara Bio
- Koichi Nakao, President, and Chief Executive Officer
- Nobuko Kawashima, Director
- Kazuko Kimura, Director
Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Takara Bio nachzuverfolgen.
Biotechnologie
Takara hat 2.276 Konkurrenten , einschließlich Eurofins (Luxemburg), Lonza (Schweiz) und Adaptive Phage Therapeutics (USA).
Popular M&A news in Biotechnologie
- Histogen has filed for bankruptcy protection (veröffentlicht am 19, April 2024).
- Bruker has announced the acquisition of NanoString Technologies (veröffentlicht am 18, April 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (veröffentlicht am 16, April 2024).
Andere vorgeschlagene Kontakte der Biotechnologie branche
Nachrichten
Neueste Pressemitteilungen nach Takara Bio
- Takara Bio Announces "SonuAAV™", a Novel AAV Vector for Efficient Gene Transfer to the Inner Ear Organ. | News Release | News Release ＆ IR News | Investor Relations
- Construction of the Center for Gene and Cell Processing III, which manufactures mRNA vaccine ingredients and enzymes for mRNA production | News Release | News Release ＆ IR News | Investor RelationsBack ButtonSearch IconFilter IconBack ButtonSearch IconFil
- Takara Bio Announces Publication of Results from NY-ESO-1・siTCR™ Gene Therapy Study in Clinical Cancer Research | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio Announces Presentation of Comparability Studies for CD19 JAK/STAT CAR-T Cell Technology Transfer | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio enters into a license agreement of RetroNectin®with Fondazione Telethon ETS | News Release | News Release ＆ IR News | Investor Relations
- Started using refrigerated boxes for transportation with consideration for the environment | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio Announces Poster Presentation of Data from Clinical Trial of NY-ESO-1・siTCR™ Gene Therapy at ASCO2023 | News Release | News Release ＆ IR News | Investor Relations
- Indian subsidiary acquires ISO13485 certification | News Release | News Release ＆ IR News | Investor Relations
- Takara Bio Announces Initiation of Clinical Trial for Next-Generation CAR-T therapy | News Release | News Release ＆ IR News | Investor Relations
- Announcement of Termination of Co-Development and Exclusive Marketing Agreements with Otsuka Pharmaceutical Co., Ltd. for NY-ESO-1・siTCR™ gene therapy candidate | News Release | News Release ＆ IR News | Investor Relations
- View more press releases Close
Social media about Takara Bio
- Takara Bio auf Wikipedia, Google News & Yahoo Finance
- Takara Bio auf LinkedIn, Twitter & YouTube
In Kontakt kommen
Jetzt seine Führungskräfte, darunter auch Koichi Nakao, per E-Mail kontaktieren. 
Takara Bio unter +81 77... anrufen
